The study “Relationship between serum vitamin C and serum uric acid in people with different BMIs: results from the NHANES 2017–2018 and Mendelian randomization study” by Jiajie Zhang et al. (2024), explored whether serum vitamin C and body mass index (BMI) are linked with serum uric acid (SUA), and whether those links may reflect cause rather than simple correlation. Published in Frontiers in Nutrition, the study matters because high SUA is linked to conditions such as gout, kidney disease, hypertension, and cardiovascular disease, underscoring the importance of understanding whether nutrition and body weight may help shape risk.

Uric acid is produced during purine metabolism, and when serum uric acid levels are too high, hyperuricemia can result, increasing the risk of gout and other health problems. The authors explain that obesity and high SUA often appear together, and earlier studies have already suggested that people with higher BMI tend to have higher uric acid. At the same time, vitamin C has attracted interest because earlier nutrition studies and trials suggested it may help lower uric acid levels, though results have not always been consistent.

This scientific paper adds value by examining both factors together rather than treating them as separate topics. The authors were especially interested in whether vitamin C might matter more for people with overweight or obesity, since obesity is linked with inflammation, oxidative stress, and metabolic changes that may affect uric acid production and removal. In the authors’ words, the findings “highlight the importance of VC” in managing SUA, especially in heavier adults.

The study used two connected approaches. First, the researchers analyzed National Health and Nutrition Examination Survey (NHANES) 2017–2018 data from 4,772 adults aged 20 and older. They measured serum vitamin C, calculated BMI, and tested serum uric acid, then used multivariable linear regression, variance inflation factor checks, stratified models, and quantile regression to study the relationships while adjusting for age, sex, race and ethnicity, poverty index, education, smoking, alcohol use, hypertension, and diabetes.

Second, the researchers conducted Mendelian randomization (MR), a method that uses inherited genetic variants to test whether an exposure is likely to have a causal effect on an outcome. They used genome-wide association study (GWAS) summary data for obesity, vitamin C, and serum uric acid, with inverse-variance weighting as the main method. This mattered because observational data alone can be confounded or subject to reverse causation, whereas MR can strengthen the case for causality when its assumptions hold.

Across the observational analysis, BMI showed a clear positive relationship with serum uric acid. In the fully adjusted model, each increase in BMI was associated with higher SUA, and people with overweight or obesity had higher uric acid levels than those with a BMI below 25. Baseline data also showed that the overweight and obese group had lower serum vitamin C and higher SUA levels on average, supporting the idea that body weight status may shape the uric acid environment.

Serum vitamin C moved in the opposite direction. In the fully adjusted model, higher vitamin C levels were associated with lower SUA. The study also found that when vitamin C was divided into quartiles, people in the highest quartile had significantly lower uric acid than those in the lowest quartile. This makes the finding easier to understand in practical terms: people with the highest measured vitamin C levels tended to have the lowest uric acid levels.

One of the most important findings was that the inverse relationship between vitamin C and uric acid looked stronger in people who were overweight or obese. In quantile regression, the uric-acid-lowering pattern became stronger as serum vitamin C increased, and this pattern was especially clear in heavier adults. Compared with the lowest vitamin C quartile, the highest quartile was linked to a notable reduction in SUA in the overweight and obesity group. The paper also found that higher vitamin C seemed to weaken, though not erase, the link between overweight or obesity and uric acid.

The Mendelian randomization results pointed in the same overall direction as the NHANES analysis. Genetically predicted obesity was associated with higher serum uric acid, while genetically predicted vitamin C was associated with lower serum uric acid. This does not make the case absolute, but it does strengthen the argument that the relationships are not just statistical noise. The authors concluded there was evidence for a “causal effect of VC and obesity on SUA.”

This scientific paper suggests that vitamin C status may matter for uric acid control, and that it may matter even more in adults with overweight or obesity. That does not mean vitamin C alone is a treatment for gout or that supplements should replace medical care. Instead, the study supports a broader message: uric acid management may benefit from considering body weight, diet quality, and metabolic health together, rather than focusing solely on medication or purine intake. The study also notes limits, including its cross-sectional design for the NHANES part, incomplete medication data, and limited generalizability beyond the studied populations. Even so, the authors say the findings “might be helpful for the management of high SUA levels.”

This scientific paper gives a clear message: higher BMI was linked with higher serum uric acid, while higher serum vitamin C was linked with lower serum uric acid, and that vitamin C pattern was strongest in people with overweight or obesity. Because the study combined a large U.S. survey with Mendelian randomization, its conclusion is more persuasive than a simple observational snapshot alone. The findings do not prove that everyone should take vitamin C supplements, but they do support the idea that maintaining healthy vitamin C levels and managing body weight may be useful parts of a broader strategy to lower uric acid risk.